in this select group of patients who are not candidates for surgical valve replacement , chronic afterload reduction with oral hydralazine may result in increased cardiac performance , decreased pulmonary congestion , reduced myocardial oxygen demands , and improvement in resting and/or exertional symptoms .
C0018787
cardiac
C0027061
myocardial